15% fall discount applied automatically at checkoutFree USA shipping over $100Free worldwide shipping over $200
Sign in 0

Semaglutide 30mg

$199.99 or subscribe for $169.99/mo

Lot PL-2609-094 tested in our lab: 99.35% purity by HPLC Certificate PL-26-00094, analysed Sep 19, 2026 · LC-MS identity, endotoxin and sterility on the certificate · details and COA images
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Safety data sheet PL-SDS-146 GHS: Warning · H351, H361 · Read the SDS · PDF

Visa, Mastercard, Discover up to $1,000 per order (charged in MXN; your bank may add a foreign-transaction fee). Pay by Bank, Zelle, Cash App or crypto: 10% off.

Semaglutide 30 mg: the largest fill of the acylated GLP-1 receptor agonist, as freeze-dried powder in a sealed vial. Each lot is tested in PrymaLab’s own laboratory and has a certificate. Sold for laboratory research use only.

Description

PrymaLab · Research use only

Semaglutide 30mg

The largest semaglutide fill: 30 mg of freeze-dried GLP-1 analogue

Semaglutide 30 mg is the largest of PrymaLab’s five semaglutide fills, with 30 mg of the peptide as freeze-dried powder in one vial. Semaglutide is a 31-residue GLP-1 receptor agonist that carries a C18 diacid for albumin binding. The research on it covers that design, receptor pharmacology and clinical trials, among them a phase 3 trial in which it was the comparator for tirzepatide.

Specifications

Semaglutide 30mg at a glance
Property Value
Compound Semaglutide NN9535; GLP-1 receptor agonist
CAS number 910463-68-2
Molecular formula C187H291N45O59
Theoretical mass 4113.6 Da
Sequence / structure H-H-Aib-EGTFTSDVSSYLEGQAAK(2×OEG-γGlu-C18 diacid)EFIAWLVRGRG-OH (31 residues; Aib8 and Arg34 in GLP-1 numbering; Lys26 acylated with octadecanedioic acid via two OEG spacers and γ-Glu; free C-terminus)
Label claim 30 mg/vial
Form Lyophilized (freeze-dried) powder or cake in a sealed glass vial with a rubber stopper and aluminium crimp cap
Storage, sealed −20 °C, desiccated, dark
Purity specification 99.0% or higher by RP-HPLC
Lot certificate Results for the lot now shipping are in the certificate panel on this page
Safety data sheet PL-SDS-146

Other fills

This is the 30 mg fill. The Semaglutide 5mg page is the main listing for this compound, with the full research summary and every fill side by side. Other fills: 5 mg, 10 mg, 15 mg, 20 mg.

What the research covers

A fill this size raises a stability question that the cited literature answers only in general terms. Reviews of protein stability separate chemical from physical degradation and compare stabilisation in solution with the dried state1; none of the papers here measured semaglutide’s life in a reconstituted research vial. In clinical work semaglutide was the active comparator in SURPASS-2, a 40-week phase 3 trial in adults with type 2 diabetes2. The Semaglutide 5 mg page has the full summary.

The Semaglutide Benefits guide covers the literature in more depth.

How each lot is tested

Every lot is tested in PrymaLab’s own laboratory in Ashland, Kentucky before release: RP-HPLC for purity, LC-MS for identity, Karl Fischer titration for water, LAL for endotoxin and USP <71> for sterility. The results for the lot now shipping are in the certificate panel on this page, and the certificate number, key and QR code can be checked on the verify page. These are in-house results from PrymaLab Analytical, not an independent test, and the lab is not accredited to ISO 17025. The third-party testing guarantee on this page still applies: if any independent laboratory finds the wrong compound, or less than the stated purity or amount, the order is refunded and the cost of the test is reimbursed.

Frequently asked questions

What limits how much of a 30 mg vial can be used at once?

Stability in solution rather than the powder. Sealed and dry, the vial keeps at −20 °C. Once dissolved it belongs at 2 to 8 °C away from light, for a period your laboratory has established, so plan the volume around how quickly the solution will be used.

How many micromoles are in 30 mg of semaglutide?

About 7.3 µmol, calculated from the theoretical mass of 4113.6 Da. The certificate's water figure means the peptide content runs a little under that, which matters most when exact molar amounts are needed.

References

  1. Manning MC, Chou DK, Murphy BM, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. DOI · PubMed
  2. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. DOI · PubMed

Research use only

For laboratory research use only. Semaglutide 30mg is not a drug, food, cosmetic or dietary supplement, is not approved by the FDA or any comparable authority for human or veterinary use, and must not be given to people or animals. It is sold to qualified researchers and institutions, and the buyer is responsible for lawful handling and disposal.

Other formats of Semaglutide

Semaglutide is also stocked as cagrilintide 2.5mg + semaglutide 2.5mg, Cagrilintide 5mg + Semaglutide 5mg, Cagrilintide 20mg preloaded 3ml pen and Cagrilintide 5mg. Each listing states its own quantity and concentration, and the pen and vial comparison explains what changes between formats.

Additional information

Weight 0.1 lbs
Dimensions N/A

Lot PL-2609-094 · Certificate of Analysis PL-26-00094

Every lot is tested in our own laboratory before it ships. These are the reference facts for this compound and the results for the lot currently shipping. Open the certificate page to verify it by QR code or number.

CompoundSemaglutide
NN9535; GLP-1 receptor agonist
CAS number910463-68-2
Molecular formulaC187H291N45O59
Theoretical mass4113.6 Da
Sequence / structureH-H-Aib-EGTFTSDVSSYLEGQAAK(2×OEG-γGlu-C18 diacid)EFIAWLVRGRG-OH (31 residues; Aib8 and Arg34 in GLP-1 numbering; Lys26 acylated with octadecanedioic acid via two OEG spacers and γ-Glu; free C-terminus)
AppearanceWhite lyophilized powder
Storage−20 °C, desiccated, dark
Label claim30 mg/vial
Lot numberPL-2609-094
Certificate numberPL-26-00094
Date of analysis2026-09-19 (retest 2028-09-18)
Purity (RP-HPLC)99.35%
Identity (LC-MS)4113.7 Da
Water content (KF)1.8%
Endotoxin (LAL)0.05 EU/mg
SterilityNo growth; conforms
ConclusionPASS
Tested byPrymaLab Analytical (PrymaLab's own laboratory, Ashland, KY). In-house result, not an independent third-party test.
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Certificate of analysis for lot PL-2609-094, page 1
Certificate page 1: results
Certificate of analysis for lot PL-2609-094, page 2
Certificate page 2: method and approval

Safety data sheet PL-SDS-146 · Semaglutide

GHS safety data sheet for this product (lyophilized powder, vial), revision 1.0 of October 3, 2026. Read all 16 sections or download the PDF to keep with the material.

Warning
  • H351 Suspected of causing cancer.
  • H361 Suspected of damaging fertility or the unborn child.
CompositionSemaglutide (CAS 910463-68-2) · ≥ 95% (dry basis, as supplied), 5 mg, 10 mg, 15 mg, 20 mg, 30 mg per vial
ClassificationCarcinogenicity (Category 2); Reproductive toxicity (Category 2)
Physical stateSolid. White to off-white lyophilized powder.
Storage−20 °C (sealed vial), desiccated and protected from light; 2–8 °C acceptable for short periods
HandlingOpen vials only in a clean area. Avoid generating or inhaling dust; weigh or reconstitute inside a ventilated enclosure when the full contents are handled as a dry powder. Reconstitute by adding diluent slowly to the vial wall; do not shake. Wash hands after handling.
First aidEyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice. Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice. Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
DisposalChemical waste through a licensed contractor; do not pour down the drain.
TransportNot regulated as a dangerous good (DOT / IATA / IMDG).

For laboratory research use only. Not for human or veterinary use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Peptide Research Articles

Semaglutide article cover image

Semaglutide Peptide: Mechanism, Trials and Research Use

Semaglutide is a 31-residue GLP-1 receptor agonist with a C18 fatty diacid side chain. This guide covers its mechanism and what the SUSTAIN, STEP and SELECT trials measured, and notes that research vials are not the prescription products.

24-hour support icon
24/7 Online support

support@prymalab.net info@prymalab.net

Quality guarantee badge icon
7-day returns

7-day returns on unopened, sealed products, plus our third-party testing guarantee.

Shipping truck icon
Free US shipping

Free USA shipping over $100 and free worldwide shipping over $200.

RealReviews.io Rate your experience with PrymaLab